SGFCX
Price
$45.85
Change
+$0.02 (+0.04%)
Updated
Jul 28 closing price
Net Assets
73.21M
VIGAX
Price
$234.68
Change
+$0.94 (+0.40%)
Updated
Jul 28 closing price
Net Assets
311.95B
Interact to see
Advertisement

SGFCX vs VIGAX

Header iconSGFCX vs VIGAX Comparison
Open Charts SGFCX vs VIGAXBanner chart's image
Sparrow Growth C
Price$45.85
Change+$0.02 (+0.04%)
VolumeN/A
Net Assets73.21M
Vanguard Growth Index Admiral
Price$234.68
Change+$0.94 (+0.40%)
VolumeN/A
Net Assets311.95B
SGFCX vs VIGAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SGFCX vs. VIGAX commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGFCX is a Buy and VIGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 312B vs. SGFCX (73.2M). VIGAX pays higher dividends than SGFCX: VIGAX (0.45) vs SGFCX (0.00). SGFCX was incepted earlier than VIGAX: SGFCX (14 years) vs VIGAX (25 years). SGFCX (2.35) is less costly to investors than VIGAX (0.05). SGFCX is a more actively managed with annual turnover of: 20.81 vs. VIGAX (11.00). SGFCX has a lower initial minimum investment than VIGAX: SGFCX (1000) vs VIGAX (3000). SGFCX (26.17) and VIGAX (26.05) have marching annual gain over last year. VIGAX return over 5 years is better than : 113.30 vs. SGFCX (33.48).
SGFCXVIGAXSGFCX / VIGAX
Total Expense Ratio2.350.054,700%
Annual Report Gross Expense Ratio2.350.054,700%
Fund Existence14 years25 years-
Gain YTD9.47911.10785%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets73.2M312B0%
Annual Yield % from dividends0.000.45-
Returns for 1 year26.1726.05100%
Returns for 3 years38.9880.9748%
Returns for 5 years33.48113.3030%
Returns for 10 years125.86314.4440%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMVP1.510.10
+7.09%
PMV Pharmaceuticals
CSTM13.930.26
+1.90%
Constellium SE
CMPX3.200.02
+0.63%
Compass Therapeutics
ASND164.16-3.31
-1.98%
Ascendis Pharma A/S
ALZN2.77-0.19
-6.42%
Alzamend Neuro Inc.